Bioline Rx reported $14M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Arca Biopharma ABIO:US USD 53.36M 13.57M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Capricor Therapeutics CAPR:US USD 46.61M 30.22M
Idera Pharmaceuticals IDRA:US USD 26.8M 2.32M
Ophthotech OPHT:US USD 153.1M 11.99M